The first-of-its-kind therapeutic approach from SetPoint Medical targets pathways intended to promote remyelination in those with relapsing-remitting #multiplesclerosis.
Medical Product Outsourcing’s Post
More Relevant Posts
-
🎊 We would like to invite you to read an #article "Clinical Response and Hospital Costs of Therapeutic Drug Monitoring for #Vancomycin in Elderly Patients" by Howard Lee, et al. Journal of Personalized Medicine MDPI link here: https://lnkd.in/gid4AY6V
To view or add a comment, sign in
-
We present results of multicenter retrospective data on patients with heavily pretreated metastatic uLMS who underwent oral pazopanib during their therapeutic journey.
To view or add a comment, sign in
-
Explore the latest therapeutic strategies to enhance outcomes in patients with #MacularDegeneration and #DiabeticMacularEdema. Free #CME #CNE offers expert analysis of new key data and more. https://bit.ly/4cZc9Om
myCME | Continuing Medical Education
To view or add a comment, sign in
-
The use of our technology in therapeutic drug monitoring!
Did you know that #massspectrometry can be used in therapeutic drug monitoring? In this case study, the Institute of Laboratory Medicine at the Hospital of Ludwig-Maximilians-University explains why they believe that further integrating mass spec into routine clinical practice can enhance diagnostic capabilities and improve patient care. Read here: https://bit.ly/3RXGk0y
To view or add a comment, sign in
-
SMS Clinical Research is inviting individuals diagnosed with Psoriasis to participate in a new clinical trial. This is an opportunity to contribute to groundbreaking research that could lead to new treatments. Your experience could be invaluable in helping others. If you're interested in participating or want more information, visit https://lnkd.in/ghBtfXny. #Psoriasis #HealthResearch #JoinNow #SMSResearch #Rewards #Trials #ClinicalTrials #ClinicalStudy #PositiveChange #Medical #Medicine #Research #Technology #LatestStudy #SMSClinicalResearch #MesquiteTX
To view or add a comment, sign in
-
Optimapharm aims to improve our understanding of endocrine and metabolic disorders, develop more effective treatments, and enhance the overall well-being of individuals affected by these conditions. With more than 17 years of continuous experience, we have: ✅successfully completed over 75 endocrine-metabolic clinical studies ✅130 highly educated, experienced and proactive SME with related experience ✅3 470 patients enrolled from more than 300 sites Explore our Factsheet and get more familiar with #Optimapharm Endocrine and Metabolic expertise. We Deliver on Your Promises! For more information, reach out to us at contact@optimapharm.eu! #ClinicalResearch #EndocrineResearch #MetabolicResearch #ClinicalTrials
To view or add a comment, sign in
-
What are the potential challenges and opportunities for pharmacotherapy in the
What are the potential challenges and opportunities for pharmacotherapy in the
https://academicfocustutors.blog
To view or add a comment, sign in
-
In this phase I trial, 114 subjects were randomized, 55 (mean age 29 years, 64% female) assigned to the single ascending dose period and 59 (mean age 32 years, 58% female) assigned to the multiple-ascending dose period, of whom 105 completed the trial. The results showed that muvalaplin reduced lipoprotein(a) [Lp(a)] levels by up to 65% without any safety concerns, providing a basis for further clinical development. Learn more about the results of this study on our website. ➡️ https://lnkd.in/eqtcRUfP #R3i #Lipoprotein #Cardiovascular #CardiovascularHealth #CVD #CardiovascularDisease #ResidualCardiovascularRisk #Muvalaplin
To view or add a comment, sign in
-
I try to deliver latest technology and guideline-directed therapeutic approach for my AF patients. Early ablation, better results...#cryoablation
To view or add a comment, sign in
-
Our latest blog post covers a recent study on the Evolving Guidelines for the Use of Touch During a Clinical Trial of Group Psilocybin-Assisted Therapy https://lnkd.in/ghMtZhTu Touch can play an important role in the therapeutic use of psychedelic medicines but consent and safety still must be the first priority. See how researchers are rethinking these two key aspects of assisted therapy.
To view or add a comment, sign in
7,100 followers